Differential effect of estrogen receptor alpha and beta agonists on the receptor for advanced glycation end product expression in human microvascular endothelial cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1745, Issue 3, 2005, Pages 300-309

  Mukherjee, Tapan K ^a   Reynolds, Paul R ^a   Hoidal, John R ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

ER ; ER ; Estrogen; NF B; RAGE; Sp1 and microvascular endothelial cell

Indexed keywords

17ALPHA ESTRADIOL; ADVANCED GLYCATION END PRODUCT RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETHINYLESTRADIOL; HORMONE RECEPTOR STIMULATING AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR SP1;

AGONIST; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; HORMONAL REGULATION; HUMAN; HUMAN CELL; MICROVASCULARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; TRANSCRIPTION INITIATION;

BLOTTING, WESTERN; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; ESTRADIOL; ESTRIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETHINYL ESTRADIOL; GENE EXPRESSION REGULATION; HUMANS; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR;

EID: 24944582119     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2005.03.012     Document Type: Article

References (27)

1. M. Neeper, A.M. Schmidt, J. Brett, S.D. Yan, F. Yang, Y.C. Pan, K. Elliston, D. Stern, and A. Shaw Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J. Biol. Chem. 267 1992 14998 15004
2. G. Basta, G. Lazzerini, M. Massaro, T. Simoncini, P. Tanganelli, F.U. Caifeng, T. Kislinger, D.M. Stern, A.M. Schmidt, and R. de Caterina Advanced glycation end products activate endothelium through signal transduction receptor RAGE: a mechanism for amplification of inflammatory responses Circulation 105 2002 816 822
3. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multi-ligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J. Clin. Invest. 108 2001 949 955
4. M. Brownlee Advanced protein glycosylation in diabetes and aging Annu. Rev. Med. 46 1995 223 234
5. M. Sun, M. Yokoyama, T. Ishiwata, and G. Asano Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat Int. J. Exp. Pathol. 79 1998 207 222
6. N. Tanaka, H. Yonekura, S. Yamagishi, H. Fujimori, Y. Yamamoto, and H. Yamamoto The receptor for advanced glycosylation end products is induced by the glycation product themselves and TNF-alpha through nuclear factor kappa B and by 17-beta-estradiol through Sp1 in human vascular endothelial cells J. Biol. Chem. 275 2000 25781 25790
7. G.G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, and J.A. Gustafsson Cloning of a novel receptor expressed in rat prostate and ovary Proc. Natl. Acad. Sci. U. S. A. 93 1996 5925 5930
8. T. Barkhem, B. Carlsson, Y. Nilsson, E. Enmark, J. Gustafsson, and S. Nilsson Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists Mol. Pharmacol. 54 1998 105 112
9. N.N. Yang, M. Venugopalan, S. Hardikar, and A. Glasebrook Identification of an estrogen response element activated by metabolites of 17-beta-estradiol and raloxifene Science 273 1996 1222 1225
10. T.K. Mukherjee, L. Nathan, H. Dinh, S.T. Reddy, and G. Chaudhuri 17-epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression J. Biol. Chem. 278 2003 11746 11752
11. W. Porter, B. Saville, D. Hoivik, and S. Safe Functional synergy between the transcription factor Sp1 and the estrogen receptor Mol. Endocrinol. 11 1997 1569 1580
12. C. Heyworth, K. Gale, M. Dexter, G. May, and T. Enver A GATA-2/estrogen receptor chimera functions as a ligand-dependent negative regulator of self-renewal Genes. Dev. 13 1999 1847 1860
13. K. Paech, P. Webb, G.G. Kuiper, S. Nilsson, J. Gustafsson, P.J. Kushner, and T.S. Scanlan Differential ligand activation of estrogen receptors ER alpha and ER beta at AP1 sites Science 277 1997 1508 1510
14. J. Li, and A.M. Schmidt Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products J. Biol. Chem. 272 1997 16498 16506
15. C. Fiuza, M. Bustin, S. Talwar, M. Tropea, E. Gerstenberger, J.H. Shelhamer, and A.F. Suffredini Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood 101 2003 2652 2660
16. E.W. Ades, F.J. Candal, R.A. Swerlick, V.G. George, S. Summers, D.C. Bosse, and T.J. Lawley Establishment of an immortalized endothelial cell line J. Invest. Dermatol. 99 1992 683 690
17. Y.K. Hodges, L. Tung, X.D. Yan, J.D. Graham, K.B. Horwitz, and L.D. Horwitz Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcription effects Circulation 101 2000 1792 1798
18. S. Yamagishi, C.C. Hsu, M. Taniguchi, S. Harada, Y. Yamamoto, K. Ohsawa, K. Kobayashi, and H. Yamamoto Receptor mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy Biochem. Biophys. Res. Commun. 213 1995 681 687
19. F. Barchiesi, E.K. Jackson, B. Imthurn, J. Fingerle, D.G. Gillespie, and R.K. Dubey Differential regulation of estrogen receptor subtypes and in human aortic smooth muscle cells by oligonucleotides and estradiol J. Clin. Endcrinol. Metab. 89 2004 2373 2381
20. D.I. Axel, I. Spyridopoulos, R. Riessen, H. Runge, R. Viebahn, and K.R. Karsch Toxicity, uptake kinetics and efficacy of new transfection reagents: increase of oligonucleotide uptake J. Vasc. Res. 37 2000 221 234
21. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The biology of the receptor for advanced glycation end products and its ligands BBA 1498 2000 99 111
22. Z. Zhou, K. Wang, M.S. Penn, S.P. Marso, M.A. Lauer, F. Forudi, X. Zhou, W. Qu, Y. Lu, D.M. Stern, A.M. Schmidt, A.M. Lincoff, and E.J. Topol Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury Circulation 107 2003 2238 2243
23. T. Sakaguchi, S.F. Yan, S.D. Yan, D. Belov, L.L. Rong, M. Sousa, M. Andrassy, S.P. Marso, S. Duda, B. Arnold, B. Liliensiek, P.P. Nawroth, D.M. Stern, A.M. Schmidt, and Y. NAKA Central role of RAGE dependent neointimal expansion in arterial restenosis J. Clin. Invest. 111 2003 959 972
24. F. Cipollone, A. Iezzi, M. Fazia, M. Zucchelli, B. Pini, C. Cuccurullo, D. De Cesare, G. De Blasis, R. Muraro, R. Bei, F. Chiarelli, A.M. Schmidt, F. Cuccurullo, and A. Mezzetti The receptor RAGE as progression factor amplifying arachidonate dependent inflammatory and proteolytic response in human atherosclerotic plaques, role of glycemic control Circulation 108 2003 1070 1077
25. K. Kim, N. Thu, B. Saville, and S. Safe Domains of estrogen receptor alpha (ER alpha) required for ER alpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells Mol. Endocrinol. 17 2003 804 817
26. L.A. deGraffenried, S.G. Hilsenbeck, and S.A. Fuqua Sp1 is essential for estrogen receptor alpha gene transcription J. Steroid Biochem. Mol. Biol. 82 2002 7 18
27. S. Safe Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions Vitam. Horm. 6 2001 231 252